Hinge Health CFO sells 781 shares in 10b5-1 trade

Hinge Health, Inc. Chief Financial Officer James Budge sold 781 shares of Class A Common Stock in an open-market transaction at $55.34 per share on May 20, 2026.

Rhea-AI Filing Summary

Hinge Health, Inc. Chief Financial Officer James Budge sold 781 shares of Class A Common Stock in an open-market transaction at $55.34 per share on May 20, 2026. After this sale, he directly holds 451,293 shares. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, and his holdings include shares issued through the company’s employee stock purchase plan.

Insider Trade Summary 10b5-1

Net Seller: 781 shares

Net Sell 1 txn

Insider Budge James

Role Chief Financial Officer

Sold 781 shs ($43K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	781	$55.34	$43K

Holdings After Transaction: Class A Common Stock — 451,293 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
2. F2. Includes 781 shares of Class A Common Stock issued to the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan.

Key Figures

Shares sold: 781 shares Sale price: $55.34 per share Post-transaction holdings: 451,293 shares +1 more

4 metrics

Shares sold 781 shares Open-market sale of Class A Common Stock on May 20, 2026

Sale price $55.34 per share Average price for the 781 shares sold

Post-transaction holdings 451,293 shares Direct Class A Common Stock owned after the sale

Net buy/sell shares -781 shares Net effect of reported transactions in this Form 4

Key Terms

Rule 10b5-1 trading plan, Class A Common Stock, employee stock purchase plan, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Class A Common Stock financial

"Includes 781 shares of Class A Common Stock issued to the Reporting Person"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

employee stock purchase plan financial

"issued to the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HNGE CFO James Budge report?

Hinge Health CFO James Budge reported selling 781 shares of Class A Common Stock. The sale was an open-market transaction executed under a Rule 10b5-1 trading plan, providing pre-arranged instructions for trading his holdings.

At what price did Hinge Health (HNGE) CFO sell his shares?

James Budge sold 781 Hinge Health Class A shares at an average price of $55.34 per share. This was reported as an open-market sale in a Form 4 insider trading report.

How many HNGE shares does the CFO hold after the reported sale?

After selling 781 shares, CFO James Budge directly holds 451,293 shares of Hinge Health Class A Common Stock. This post-transaction balance is disclosed in the Form 4 as his remaining direct ownership position.

Was the Hinge Health CFO’s share sale under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes state the sale was effected under a Rule 10b5-1 trading plan. Such plans allow insiders to schedule trades in advance, reducing the significance of trade timing as an information signal.

Are employee stock purchase plan shares included in the CFO’s HNGE holdings?

Yes. A Form 4 footnote explains that his reported holdings include 781 shares of Class A Common Stock issued on May 15, 2026 under Hinge Health’s employee stock purchase plan, along with his other directly held shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 04:36 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/20/2026		S(1)		781	D	$55.34	451,293(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.

2. Includes 781 shares of Class A Common Stock issued to the Reporting Person on May 15, 2026 pursuant to the Issuer's employee stock purchase plan.

	/s/ James Budge	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)